Magnolol may contribute to barrier function improvement on imiquimod-induced psoriasis-like dermatitis animal model via the downregulation of interleukin-23.

Guo, Jiun-Wen; Cheng, Yu-Pin; Liu, Chih-Yi; Thong, Haw-Yueh; Lo, Yang; Wu, Chen-Yu; Jee, Shiou-Hwa

Guo, Jiun-Wen; Cheng, Yu-Pin; Liu, Chih-Yi; Thong, Haw-Yueh; Lo, Yang; Wu, Chen-Yu; Jee, Shiou-Hwa.

Afiliação

Guo JW; Department of Medical Research, Cathay General Hospital, Taipei 10630, Taiwan, R.O.C.
Cheng YP; College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan, R.O.C.
Liu CY; Department of Dermatology, Cathay General Hospital, Taipei 10630, Taiwan, R.O.C.
Thong HY; Division of Pathology, Sijhih Cathay General Hospital, New Taipei City 22174, Taiwan, R.O.C.
Lo Y; Department of Dermatology, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei 11101, Taiwan, R.O.C.
Wu CY; Department of Dermatology, Cathay General Hospital, Taipei 10630, Taiwan, R.O.C.
Jee SH; Department of Dermatology, Cathay General Hospital, Taipei 10630, Taiwan, R.O.C.

Exp Ther Med ; 21(5): 448, 2021 May.

Article em En | MEDLINE | ID: mdl-33747183